Alectinib synthetic routes

CAT#: 326631 | Name: Deutetrabenazine | CAS#

Purchases for research

Description:

Deutetrabenazine, also known as SD-809 and Tetrabenazine-d6, is an investigational, oral, small-molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD-809 is being developed for the treatment of chorea associated with Huntington’s disease, a neurodegenerative movement disorder that impacts cognition, behavior, and movements. Teva is investigating the broad potential of SD-809 for treating additional movements disorders such as tardive dyskinesia and tics associated with Tourette syndrome.

Synthetic Routes

Deutetrabenazine - Synthetic Route 1

Deutetrabenazine - Synthetic Route 1

Synthetic reference

Chandra Ray, Purna & Dadaji Pawar, Yogesh & Tukaram Singare, Dnyaneshwar & Nandkumar Deshpande, Tushar & Pal Singh, Girij. (2018). Novel Process for Preparation of Tetrabenazine and Deutetrabenazine. Organic Process Research & Development. 22. 10.1021/acs.oprd.8b00011.

Deutetrabenazine - Synthetic Route 2

Deutetrabenazine - Synthetic Route 2

Synthetic reference

Shah, Pratik; Saks, Samuel. Benzoquinolines as inhibitors of vesicular monoamine transporter 2 and their preparation. WO 2015077521. (Assignee Auspex Pharmaceuticals, Inc., USA)

Deutetrabenazine - Synthetic Route 3

Deutetrabenazine - Synthetic Route 3

Synthetic reference

Zhang, Chengzhi. Methods of manufacturing benzoquinoline compounds as inhibitors of vesicular monoamine transporter 2 (VMAT2). US 20150152099. (Assignee Auspex Pharmaceuticals, Inc., USA)

Deutetrabenazine - Synthetic Route 4

Deutetrabenazine - Synthetic Route 4

Synthetic reference

Despande, Tushar Nandkumar; Singare, Dnyaneshwar Tukaram; Pawar, Yogesh Dadaji; Chavan, Yuvraj Atmaram; Ray, Purna Chandra; Singh, Girij Pal. Novel process for the preparation of tetrabenazine and deutetrabenazine. WO 2017182916. (Assignee Lupin Limited, India)

Deutetrabenazine - Synthetic Route 5

Deutetrabenazine - Synthetic Route 5

Synthetic reference

Shah, Pratik. Preparation of benzoquinolines as for treatment of abnormal muscular activity. WO 2015077520. (Assignee Auspex Pharmaceuticals, Inc., USA)

Deutetrabenazine - Synthetic Route 6

Deutetrabenazine - Synthetic Route 6

Synthetic reference

Zhang, Chengzi; Kerr, Jim. Analogs of deutetrabenazine, their preparation and use. WO 2018170214.

Deutetrabenazine - Synthetic Route 7

Deutetrabenazine - Synthetic Route 7

Synthetic reference

Jayachandra, Sureshbabu; Srinivasarao, Attanti Veera Venkata; Rathinapandian, Jabaraj; Chandupatla, Shivakumar; Kommaraju, Srinivas. Methods and intermediates for preparing deutetrabenazine. Assignee Mylan Laboratories Ltd., India.IN 201741047280. 2019.

Deutetrabenazine - Synthetic Route 8

Deutetrabenazine - Synthetic Route 8

Synthetic reference

Alaparthi, Lakshmi Prasad; Sharma, Uday; Reddy, Gangireddy Kamalakar. A novel process for preparation of deutetrabenazine. WO 2019150387. 2019.